515 related articles for article (PubMed ID: 29164570)
21. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA
Roldán V; Rivera-Caravaca JM; Shantsila A; García-Fernández A; Esteve-Pastor MA; Vilchez JA; Romera M; Valdés M; Vicente V; Marín F; Lip GYH
Ann Med; 2018 Feb; 50(1):26-34. PubMed ID: 28892413
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of CHA
Ording AG; Horváth-Puhó E; Prandoni P; Leisner MZ; Farkas DK; Steffensen FH; Olsen M; Sørensen HT; Schmidt M
Am J Cardiol; 2019 Oct; 124(7):1059-1063. PubMed ID: 31376914
[TBL] [Abstract][Full Text] [Related]
23. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
24. CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation.
Wei-Syun Hu ; Lin CL
Lupus; 2018 Jul; 27(8):1240-1246. PubMed ID: 29554836
[TBL] [Abstract][Full Text] [Related]
25. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.
Chao TF; Huang YC; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Hsieh MH; Lip GY; Chen SA
Heart Rhythm; 2014 Nov; 11(11):1941-7. PubMed ID: 25101483
[TBL] [Abstract][Full Text] [Related]
26. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
Rivera-Caravaca JM; Marín F; Vilchez JA; Gálvez J; Esteve-Pastor MA; Vicente V; Lip GYH; Roldán V
Stroke; 2019 Jun; 50(6):1372-1379. PubMed ID: 31084333
[TBL] [Abstract][Full Text] [Related]
27. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
[TBL] [Abstract][Full Text] [Related]
28. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?
Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Wu TJ; Chen TJ; Tsao HM; Chen SA
Stroke; 2012 Oct; 43(10):2551-5. PubMed ID: 22871677
[TBL] [Abstract][Full Text] [Related]
29. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
[TBL] [Abstract][Full Text] [Related]
30. Relation of red blood cell distribution width with CHADS
Liu T; Shao Q; Korantzopoulos P; Miao S; Zhang Z; Xu G; Yuan R; Li G
Int J Cardiol; 2017 Feb; 228():861-864. PubMed ID: 27889552
[TBL] [Abstract][Full Text] [Related]
31. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
[TBL] [Abstract][Full Text] [Related]
32. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
[TBL] [Abstract][Full Text] [Related]
33. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
[TBL] [Abstract][Full Text] [Related]
34. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
35. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
Guo Y; Wang H; Tian Y; Wang Y; Lip GY
Thromb Haemost; 2016 Jan; 115(1):184-92. PubMed ID: 26322338
[TBL] [Abstract][Full Text] [Related]
36. CHA
Rapacciuolo A; Mancusi C; Canciello G; Izzo R; Strisciuglio T; de Luca N; Ammirati G; de Simone G; Trimarco B; Losi MA
Sci Rep; 2019 May; 9(1):7888. PubMed ID: 31133712
[TBL] [Abstract][Full Text] [Related]
37. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
38. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
39. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
40. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
